Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 08, 2025 07:00 ET | Source: Ocular Therapeutix, Inc.

Ocular Therapeutix™ Announces Plans to Accelerate NDA Submission Timeline for AXPAXLI™ in Wet AMD

Ocular intends to submit AXPAXLI New Drug Application (NDA) for wet AMD shortly after year one data from SOL-1, if positive SOL-1 topline data remain on track for 1Q 2026 Ocular plans to leverage...
December 08, 2025 07:00 ET | Source: IRIDEX Corporation

Iridex Announces New Thermal Dynamics Study That Strengthens Clinical Foundation and Market Potential of MicroPulse® Technology and Continuous-Wave Laser for Glaucoma Treatment

MOUNTAIN VIEW, Calif., Dec. 08, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and...
December 07, 2025 08:05 ET | Source: SNS Insider pvt ltd

Ophthalmic Drugs Market Size to Cross USD 62.74 Billion by 2032, Driven by Advances in Eye Care Treatments and Rising Global Vision Disorders - SNS Insider

Austin, Texas, Dec. 07, 2025 (GLOBE NEWSWIRE) -- Ophthalmic Drugs Market Size & Growth Outlook According to SNS Insider, The Ophthalmic Drugs Market size was valued at USD 37.35 billion in 2023...
December 05, 2025 07:30 ET | Source: AstuteAnalytica India Pvt. Ltd.

Taiwan Myopia Control Lenses Market to Worth Over US$ 140.60 Million By 2033 | Astute Analytica

Chicago, Dec. 05, 2025 (GLOBE NEWSWIRE) -- The Taiwan myopia control lenses market was valued at US$ 49.30 million in 2024 and is projected to reach US$ 140.60 million by 2033, growing at a CAGR of...
December 05, 2025 07:26 ET | Source: Research and Markets

U.S. AI-Driven Retinal Screening Device Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034

Dublin, Dec. 05, 2025 (GLOBE NEWSWIRE) -- The "U.S. AI-Driven Retinal Screening Device Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034" report has been added to ...
December 05, 2025 07:00 ET | Source: IRIDEX Corporation

Iridex to Present at the Sidoti Year-End Virtual Investor Conference

MOUNTAIN VIEW, Calif., Dec. 05, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and...
December 04, 2025 07:30 ET | Source: AstuteAnalytica India Pvt. Ltd.

China Myopia Control Lenses Market Set to Hit Valuation of US$ 935.60 Million by 2033 | Astute Analytica

Chicago, Dec. 04, 2025 (GLOBE NEWSWIRE) -- The China myopia control lenses market was valued at US$ 317.0 million in 2024 and is projected to reach US$ 935.60 million by 2033, growing at a CAGR of...
December 03, 2025 07:00 ET | Source: OKYO Pharma LTD

OKYO Pharma Announces Chairman and Founder Acquires Shares

LONDON and NEW YORK, Dec. 03, 2025 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), an ophthalmology-focused bio-pharmaceutical company which is developing urcosimod to treat neuropathic...
December 03, 2025 07:00 ET | Source: Iolyx Therapeutics, Inc.

Iolyx Therapeutics Enters Strategic Agreement with Laboratoires Théa to Develop and Commercialize ILYX-002 intended for the Treatment of Autoimmune Associated Dry Eye Disease and Secures Series B Funding for Retinal Pipeline

Deal with Laboratoires Théa representing a total value of up to $280 million including clinical, regulatory and commercial conditional milestones, commercial royalties, and development responsibility...
December 02, 2025 17:10 ET | Source: Spherix Global Insights

Conflicting Guidance and Rapid Innovation Leave Physicians Seeking Clarity in Relapsed/Refractory Multiple Myeloma

EXTON, PA, Dec. 02, 2025 (GLOBE NEWSWIRE) -- “Relapsed/Refractory Multiple Myeloma (RRMM) is difficult to manage because there’s no clear, consistent guidance – ask five academic physicians and...